Literature DB >> 31392354

[Unclear limitation in flexion of the left hip joint in a 35-year-old man].

C Skusa1, C C Harms2, M-A Weber3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31392354     DOI： 10.1007/s00117-019-0580-z

Source DB:  PubMed          Journal:  Radiologe        ISSN： 0033-832X            Impact factor:   0.635


× No keyword cloud information.
  11 in total

Review 1.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

Review 2.  [Imaging characteristics of malignant and benign lesions of skeletal muscle].

Authors:  L Leonard; H J Meyer; A Surov
Journal:  Radiologe       Date:  2017-12       Impact factor: 0.635

3.  Synovial chondromatosis.

Authors:  G Hermann; I F Abdelwahab; M Klein; S Kenan; M Lewis
Journal:  Skeletal Radiol       Date:  1995-05       Impact factor: 2.199

Review 4.  The imaging of myositis ossificans.

Authors:  Philippa Tyler; Asif Saifuddin
Journal:  Semin Musculoskelet Radiol       Date:  2010-05-18       Impact factor: 1.777

Review 5.  [Value of a combined ossification prophylaxis with indomethacin and radiotherapy for acetabular fractures].

Authors:  S Piatek; T Westphal; D Arbter; S Winckler
Journal:  Unfallchirurg       Date:  2006-07       Impact factor: 1.000

6.  Periosteal chondrosarcoma and periosteal osteosarcoma. Two distinct entities.

Authors:  F Bertoni; S Boriani; M Laus; M Campanacci
Journal:  J Bone Joint Surg Br       Date:  1982

7.  Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.

Authors:  Carlo L Romanò; Dario Duci; Delia Romanò; Mario Mazza; Enzo Meani
Journal:  J Arthroplasty       Date:  2004-01       Impact factor: 4.757

8.  Celecoxib and heterotopic bone formation after total hip arthroplasty.

Authors:  Carlos J Lavernia; Juan S Contreras; Jesus M Villa; Mark D Rossi
Journal:  J Arthroplasty       Date:  2013-08-06       Impact factor: 4.757

9.  Prophylactic Celecoxib Administration Is Associated With Decreased Incidence and Severity of Heterotopic Ossification After Hip Resurfacing by Direct Lateral Approach in Male Patients.

Authors:  Mitchell Ng; David Brigati; Timothy C Wagner; Kevin Bigart; Anton Khlopas; Assem A Sultan; Michael A Mont; Peter Brooks
Journal:  Orthopedics       Date:  2018-09-18       Impact factor: 1.390

Review 10.  Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac.

Authors:  Chris Walker
Journal:  Int J Rheumatol       Date:  2018-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.